Contravisory Investment Management’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Sell
753
-433
-37% -$288K 0.11% 141
2026
Q1
$646K Sell
1,186
-60
-5% -$24.5K 0.13% 127
2025
Q4
$390K Sell
1,246
-160
-11% -$50.8K 0.08% 164
2025
Q3
$380K Sell
1,406
-42
-3% -$9.62K 0.07% 181
2025
Q2
$319K Buy
+1,448
New +$261K 0.06% 193
2018
Q1
Sell
-13
Closed -$1K 331
2017
Q4
$1K Hold
13
﹤0.01% 343
2017
Q3
$1K Buy
+13
New +$816 ﹤0.01% 389
2015
Q1
Sell
-220
Closed -$7K 160
2014
Q4
$7K Hold
220
﹤0.01% 138
2014
Q3
$7K Hold
220
﹤0.01% 119
2014
Q2
$8K Buy
+220
New +$6.6K ﹤0.01% 116

Other funds holding AGX

Contravisory Investment Management's AGX Position: Q2 2026 in Review

Contravisory Investment Management reduced its Argan (AGX) stake by 37% in Q2 2026, selling an estimated $288K and leaving 753 shares worth $601K. The position accounts for 0.11% of the portfolio, ranked #141.

Contravisory Investment Management first reported a position in AGX in Q2 2014 and has held it in 10 quarters since. The position peaked at $646K in Q1 2026. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Contravisory Investment Management held 753 shares of Argan worth $601K as of Q2 2026.
  • Contravisory Investment Management sold 433 Argan shares in Q2 2026, an estimated $288K.
  • Argan made up 0.11% of Contravisory Investment Management's portfolio in Q2 2026, its #141 holding.
  • Contravisory Investment Management first reported a position in Argan in Q2 2014 and has held it in 10 quarters since.
  • Contravisory Investment Management's Argan position peaked at $646K in Q1 2026.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.